Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up.

Por de Mascarel, I., Bonichon, F., Coindre, J. M., Trojani, M.
Publicado em 1992

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance.

Por Trojani, M., de Mascarel, I., Coindre, J. M., Bonichon, F.
Publicado em 1987

Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas

Por Bonora, E, Evangelisti, C, Bonichon, F, Tallini, G, Romeo, G
Publicado em 2006

Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.

Por Trojani, M., de Mascarel, I., Bonichon, F., Coindre, J. M., Delsol, G.
Publicado em 1987

Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.

Por Soubeyran, I., Quénel, N., Mauriac, L., Durand, M., Bonichon, F., Coindre J-M
Publicado em 1996

Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.

Por Lagarde, P., Bonichon, F., Eghbali, H., de Mascarel, I., Chauvergne, J., Hoerni, B.
Publicado em 1989

Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

Por Rudolph, P., Kellner, U., Chassevent, A., Collin, F., Bonichon, F., Parwaresch, R., Coindre, J. M.
Publicado em 1997

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

Por Soubeyran, I., Quénel, N., Coindre, J. M., Bonichon, F., Durand, M., Wafflart, J., Mauriac, L.
Publicado em 1996

Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas

Por Soubeyran, P, Hostein, I, Debled, M, Eghbali, H, Soubeyran, I, Bonichon, F, Astier-Gin, T, Hœrni, B
Publicado em 1999

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

Por MacGrogan, G., Mauriac, L., Durand, M., Bonichon, F., Trojani, M., de Mascarel, I., Coindre, J. M.
Publicado em 1996

Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.

Por Ravaud, A., Bui, N. B., Coindre, J. M., Lagarde, P., Tramond, P., Bonichon, F., Stöckle, E., Kantor, G., Trojani, M., Chauvergne, J.
Publicado em 1992